Body’s own cells are focus of type 1 diabetes clinical trial
Sanford Health is collaborating with Caladrius Biosciences, Inc., a New Jersey-based cell-therapy company, on a clinical trial that explores whether increasing the number of a person’s regulatory T cells (Treg cells) can help adolescents fight newly onset type 1 diabetes. The trial, known as “The Sanford Project: T-Rex Study” (NCT02691247), tests the safety and effectiveness […]